Gene therapy plus angioplasty for severe leg blockages
Part of Blood & lymphatic, Heart & circulation clinical trials.
This study tests if adding gene therapy to a standard leg artery-opening procedure (angioplasty or stenting) helps people with severe leg pain or non-healing wounds due to blocked arteries. It may improve blood flow and save the leg from amputation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a blocked artery in your leg causing severe pain at rest or a non-healing sore
- You have not had any surgery on that leg before
- You are not pregnant or breastfeeding
- You are not currently on chemotherapy or radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to open blocked arteries below the knee in people with severe leg wounds due to poor blood flow (chronic limb-threatening ischemia). The goal is to help wounds heal and save the leg from amputation.
This trial tests whether injecting stem cells from donated fat tissue can help people with severe blockages in leg arteries who cannot have surgery or angioplasty. The goal is to see if the treatment is safe and if it can improve blood flow and reduce pain or wounds.
This study tests a new way to restore blood flow to the leg in people who have wounds or dead tissue on their foot and have run out of other treatment options. It's for those who have already tried angioplasty twice without success or have severely hardened small arteries.
This trial tests whether stem cells from umbilical cord arteries can help people with severe leg pain or ulcers due to blocked arteries. It is for those who cannot have surgery or other procedures.
This study is testing a new drug-coated stent for blocked arteries in the thigh or behind the knee. It may help people with moderate to severe leg pain or wounds by improving blood flow without needing surgery.
This study follows up with people who previously took part in a clinical trial testing an experimental gene therapy for critical limb ischemia (severe leg pain or sores due to blocked arteries). It aims to see how well the treatment works over time. If you were in that earlier trial and received at least one dose, joining this follow-up could help researchers learn more about the therapy's lasting effects.
Hear when a new Severe Lower Limb Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.